Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Typhaneoside is a flavonoid glycoside that has been found in T. angustifolia and has diverse biological activities.1,2,3,4 It decreases colony size and induces ferroptosis and cell cycle arrest at the G2/M phase in Kasumi-1 and NB4 leukemia cells when used at a concentration of 40 µM.1 Typhaneoside (70 µM) reduces LPS-induced decreases in cell viability, increases in malondialdehyde (MDA) and nitric oxide (NO) levels, and decreases in superoxide dismutase (SOD) activity in human umbilical vein endothelial cells (HUVECs).2 It limits increases in glutamate secretion and intracellular calcium levels induced by the non-specific voltage-gated potassium channel blocker 4-aminopyridine (Item No. 18511) in isolated rat cerebral synaptosomes when used at a concentration of 20 µM.3 Typhaneoside, in complex with a tetrahedral framework nucleic acid (tFNA), decreases the area and severity of necrotic kidney tissue, the number of apoptotic kidney cells, blood urea nitrogen and serum creatinine levels, and increases mitochondrial membrane integrity in isolated kidney cells in a mouse model of renal ischemia-reperfusion injury induced by bilateral renal pedicle clamping.4
WARNING This product is not for human or veterinary use.
1. Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy. Biochem. Biophys. Res. Commun. 516(4), 1265-1271 (2019).
2. Antioxidant capacity of Typha angustifolia extracts and two active flavonoids. Pharm. Biol. 55(1), 1283-1288 (2024).
3. Typhaneoside suppresses glutamate release through inhibition of voltage-
4. Typhaneoside-